A. Roussaki‐Schulze

Effectiveness and safety of apremilast in biologic‐naïve patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study

C. Antoniou, A. Drosos, E. Lazaridou, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis.

E. Rallis, E. Zafiriou, E. Klimi, 2005, Drugs under experimental and clinical research.

Increasing incidence of melanoma in central Greece: a retrospective epidemiological study.

E. Rallis, E. Zafiriou, E. Klimi, 2005, International journal of tissue reactions.

Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.

E. Rallis, A. Roussaki‐Schulze, C. Kouskoukis, 2005, Drugs under experimental and clinical research.

Evaluation of cytokine serum levels in patients with plaque-type psoriasis.

E. Petinaki, E. Rallis, E. Zafiriou, 2005, International journal of clinical pharmacology research.

Objective biophysical findings in patients with sensitive skin.

E. Zintzaras, E. Rallis, E. Zafiriou, 2005, Drugs under experimental and clinical research.

Oral administration of cyclosporin A in patients with severe alopecia areata.

E. Rallis, A. Roussaki‐Schulze, C. Kouskoukis, 2005, International journal of tissue reactions.

Drugs associated with bullous pemphigoid: role of ΗΜG‐COa reductase inhibitors

E. Zafiriou, A. Roussaki‐Schulze, A. Papadopoulou, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.